Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes (Q81661579)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 May 2005

Language	Label	Description	Also known as
English	Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes	scientific article published on 01 May 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837231%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837231%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

based on heuristic

inferred from title

Pseudomonas aeruginosa

object named as

Pseudomonas aeruginosa

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837231%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Zengzu Lai

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837231%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Rhonda Kimmel

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837231%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Sheryl Petersen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837231%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Sharon Thomas

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837231%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Binyam Bezabeh

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837231%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Robin Luo

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837231%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

John R Schreiber

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837231%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837231%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837231%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837231%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837231%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

3264-3271

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837231%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Human antibodies elicited by a pneumococcal vaccine express idiotypic determinants indicative of V(H)3 gene segment usage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

Tissue-specific Fc gamma and complement receptor expression by alveolar macrophages determines relative importance of IgG and complement in promoting phagocytosis of Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

Production and characterization of a human hyperimmune intravenous immunoglobulin against Pseudomonas aeruginosa and Klebsiella species

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

Pseudomonas aeruginosa polysaccharide-tetanus toxoid conjugate vaccine: safety and immunogenicity in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

Pseudomonas aeruginosa bacteremia in immunocompromised children: analysis of factors associated with a poor outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

Regulation of B cell development by variable gene complexity in mice reconstituted with human immunoglobulin yeast artificial chromosomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

Treatment of experimental Pseudomonas aeruginosa pneumonia with a human IgM monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

Summary of antibody workshop: The Role of Humoral Immunity in the Treatment and Prevention of Emerging and Extant Infectious Diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

Molecular ontogeny of the human antibody repertoire to the Haemophilus influenzae type B polysaccharide: expression of canonical variable regions and their variants in vaccinated infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

Safety and immunogenicity of high molecular weight polysaccharide vaccine from immunotype 1 Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

Fatal pseudomonas infection in burned patients. A clinical, bacteriologic and anatomic study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

Production of protective human antipneumococcal antibodies by transgenic mice with human immunoglobulin loci

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

Safety, pharmacokinetics, and functional activity of human anti-Pseudomonas aeruginosa monoclonal antibodies in septic and nonseptic patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

Variable region-identical monoclonal antibodies of different IgG subclass directed to Pseudomonas aeruginosa lipopolysaccharide O-specific side chain function differently

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

Pseudomonas hyperimmune globulin passive immunotherapy for pulmonary exacerbations in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

A human monoclonal antibody that protects mice against Pseudomonas-induced pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

Outer membrane protein F preparation of Pseudomonas aeruginosa as a vaccine against chronic pulmonary infection with heterologous immunotype strains in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

based on heuristic

inferred from DOI database lookup

Complex serology and immune response of mice to variant high-molecular-weight O polysaccharides isolated from Pseudomonas aeruginosa serogroup O2 strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

based on heuristic

inferred from DOI database lookup

Smooth lipopolysaccharide is the major protective antigen for mice in the surface extract from IATS serotype 6 contributing to the polyvalent Pseudomonas aeruginosa vaccine PEV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro and in vivo activity of polyclonal and monoclonal human immunoglobulins G, M, and A against Pseudomonas aeruginosa lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

based on heuristic

inferred from DOI database lookup

Human monoclonal antibodies that protect mice against challenge with Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.088

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.01.088

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837231%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837231%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81661579&oldid=1753307636"